Empowered Funds LLC Makes New Investment in Globe Life Inc. $GL

Empowered Funds LLC acquired a new stake in Globe Life Inc. (NYSE:GL) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 23,134 shares of the company’s stock, valued at approximately $4,134,000.

Other institutional investors also recently modified their holdings of the company. CYBER HORNET ETFs LLC acquired a new position in shares of Globe Life during the second quarter worth approximately $28,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Globe Life in the fourth quarter valued at approximately $30,000. MUFG Securities EMEA plc acquired a new stake in shares of Globe Life in the second quarter valued at approximately $31,000. Johnson Financial Group Inc. bought a new position in Globe Life in the 2nd quarter worth approximately $39,000. Finally, AdvisorNet Financial Inc raised its position in shares of Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after acquiring an additional 92 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Frank M. Svoboda sold 10,000 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $166.68, for a total value of $1,666,800.00. Following the sale, the chief executive officer directly owned 54,020 shares in the company, valued at $9,004,053.60. This trade represents a 15.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Thomas Peter Kalmbach sold 21,000 shares of the stock in a transaction that occurred on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total transaction of $3,781,260.00. Following the completion of the sale, the chief financial officer owned 50,568 shares in the company, valued at $9,105,274.08. This represents a 29.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 151,908 shares of company stock worth $27,239,981 over the last quarter. Insiders own 2.11% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Morgan Stanley lifted their price objective on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Piper Sandler raised their target price on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Weiss Ratings cut shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. TD Cowen lifted their price target on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Globe Life Stock Down 0.1%

Shares of Globe Life stock opened at $172.59 on Tuesday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The business has a fifty day simple moving average of $178.78 and a 200 day simple moving average of $159.87. The stock has a market cap of $13.26 billion, a PE ratio of 11.46 and a beta of 0.48.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the company posted $3.05 EPS. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts predict that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life declared that its Board of Directors has initiated a stock repurchase plan on Monday, August 10th that permits the company to repurchase $2.50 billion in shares. This repurchase authorization permits the company to buy up to 17.7% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its shares are undervalued.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life’s payout ratio is presently 8.76%.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.